Conference abstractPublished 17 May 2018
Association of plasma and mid-brain metabolites with 6-OHDA induced in vivo Parkinsonism
King′s College London, UK The University of Hong Kong, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ParkinsonâÂ?Â?s Disease (PD) is a debilitating neurodegenerative disorder, with no cure at present. An in-depth understanding of the pathology of PD will pave ways for effective treatment options. In recent years metabolomics has emerged as a powerful tool to identify biomarkers and mechanisms for a range of diseases. The aim of this study was to use systems metabolomics to identify changes in an in vivo model of PD. Male Sprague-Dawley rats were injected with the toxin 6-hydroxydopamine (6OHDA) into the mid-brain, to induce Parkinsonism. Animals injected with saline were used as the control group. Two weeks after the injection, behavior tests were carried out to assess motor dysfunction, followed by plasma and brain collection for untargeted metabolic profiling. Palmitic acid (p=1.76x10-2, q=3.72x10-2, FC=1.81) and stearic acid (p=2.56x10-2, q=3.84x10-2, FC=2.15) were significantly up-regulated in the plasma of the PD group, while mono-palmitin (p=2.4x10-2, q=4.8x10-2, FC=11.7), mono-stearin (p=3.1x10-2, q=3.72x10-2, FC=-15.1) and myoinositol (p=3.81x10-2, q=3.81x10-2, FC=-3.32) showed a significant imbalance in their mid-brains. Receiver operating characteristic (ROC) curves showed that all these metabolites had an area under the curve (AUC) of >0.8, which indicates good prediction ability. Furthermore, the plasma metabolites were significantly correlated with the behavior test scores. These results show that plasma saturated free fatty acids and their monoglycerides in the brain were associated with 6-OHDA induced toxicity. All these metabolites showed good prediction ability. The plasma fatty acids also had a strong correlation with motor dysfunction, an integral symptoms of PD, suggestive of their potential as biomarkers.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Anuri Shah”
- BylineArticles whose byline prints “Pei Han”
- BylineArticles whose byline prints “Raymond Cheun-Chung Chang”
- BylineArticles whose byline prints “Cristina Legido-Quigley”
